Infimer (Israel) Technical Analysis

INFR Stock  ILA 20,890  15,890  317.80%   
As of the 15th of December 2024, Infimer retains the Risk Adjusted Performance of 0.1632, market risk adjusted performance of 728.42, and Downside Deviation of 56.95. Infimer technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Infimer Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Infimer, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Infimer
  
Infimer's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Infimer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Infimer technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Infimer trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Infimer Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Infimer volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Infimer Trend Analysis

Use this graph to draw trend lines for Infimer. You can use it to identify possible trend reversals for Infimer as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Infimer price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Infimer Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Infimer applied against its price change over selected period. The best fit line has a slop of   110.27  , which means Infimer will continue producing value for investors. It has 122 observation points and a regression sum of squares at 4.598463444E8, which is the sum of squared deviations for the predicted Infimer price change compared to its average price change.

About Infimer Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Infimer on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Infimer based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Infimer price pattern first instead of the macroeconomic environment surrounding Infimer. By analyzing Infimer's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Infimer's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Infimer specific price patterns or momentum indicators. Please read more on our technical analysis page.

Infimer December 15, 2024 Technical Indicators

Most technical analysis of Infimer help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Infimer from various momentum indicators to cycle indicators. When you analyze Infimer charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Complementary Tools for Infimer Stock analysis

When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements